MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
Saved in:
Mitchell, J.M., et al., MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine, vol. 27, 2021, p. 1025-1033.
Ref.
569233
Location:
SIIS Archivo
Palabras clave:
Enfermedades mentales, Trastornos psiquiátricos, Tratamiento, Drogodependencias, Drogas de síntesis, Éxtasis, Efectos, Datos estadísticos
Enfermedades mentales, Trastornos psiquiátricos, Tratamiento, Drogodependencias, Drogas de síntesis, Éxtasis, Efectos, Datos estadísticos
Similar Items: MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
- A PHASE 3 PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTI-SITE TRIAL OF THE ALPHA-2-ADRENERGIC AGONIST, LOFEXIDINE, FOR OPIOID WITHDRAWAL
- RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED TRIAL OF MODAFINIL FOR THE TREATMENT OF METHAMPHETAMINE DEPENDECE
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF RITANSERIN PHARMACOTHERAPY FOR COCAINE DEPENDENCE
- Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial
- Randomized, placebo-controlled, double-blind trial of Swedish snus for smoking reduction and cessation
- Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial